
Radyus Research: Collaborative preclinical drug development and strategic consulting services.
Founded with the mission to accelerate drug development, Radyus Research is a collaborative research organization specializing in preclinical drug development services and strategic consulting. The company aims to streamline the drug development process from lead optimization to clinical proof of concept, integrating scientific expertise and operational execution to meet unique client needs. Radyus Research focuses on serving pharmaceutical and biotechnology companies, offering comprehensive support across pre-clinical, clinical, manufacturing, and regulatory stages.
Notable figures affiliated with Radyus Research include experienced scientists and strategic consultants who bring extensive industry knowledge to the table. The company has garnered attention for its ability to seamlessly integrate into client teams, providing tailored solutions that expedite drug development timelines. Radyus Research's impact is evident in its successful partnerships and contributions to advancing numerous drug candidates through critical development phases, ultimately enhancing the efficiency and effectiveness of the pharmaceutical development pipeline.
Companies similar to Radyus Research include PharmaDirections, Confluence Discovery Technologies, Radicle Science and Odyssey Research.
Radyus Research was founded in 2019.
Radyus Research's headquarters is located in Atlanta, GA, US.
Radyus Research's most recent funding round was for $200k (USD) in February 2020.
As of Feb 23, 2020, Radyus Research has disclosed funding of $200k (USD). Undisclosed round amounts are excluded.
Radyus Research has 11 employees as of Feb 5, 2024.
Odyssey Research